Fierce Pharma

FEBRUARY 7, 2023

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08

Government 312

Government 312

Clarivate

FEBRUARY 9, 2023

After many months of planning, we are launching the Preprint Citation Index , a multidisciplinary collection of preprints from leading repositories that helps researchers stay current with the newest research while maintaining confidence in the resources they rely on. With the launch of the Preprint Citation Index , we are making it even easier for researchers to include preprints in their existing research workflows.

Leads 145

Leads Government Management 145

MedCity News

FEBRUARY 7, 2023

Virta is available this month to all Blue Shield of California members enrolled in preferred provider organization plans for individual and family, fully insured, self funded and Medicare Advantage. The payer has been working with Virta since 2019 when the digital health company joined Blue Shield of California’s Wellvolution, a platform of digital lifestyle apps.

Networking 129

Networking Insurance 129

Medgadget

FEBRUARY 7, 2023

Engineers at the University of California San Diego have developed a wearable ultrasound system for cardiac imaging. The postage stamp-sized patch can be worn on the skin of the chest and uses AI and ultrasound waves to perform advanced imaging of the heart. The technology can even be worn to perform cardiac ultrasound imaging during exercise. Each patch can be worn for up to 24 hours, and provides information on how much blood the heart is pumping, a key metric in detecting and appraising a var

Engineering 129

Engineering Leads 129

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

FEBRUARY 8, 2023

BREAKING: Bayer taps Roche vet Anderson as its next CEO, pushing out Baumann esagonowsky Wed, 02/08/2023 - 11:28

299

299

European Pharmaceutical Review

FEBRUARY 7, 2023

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. Changes have been spurred by the COVID-19 pandemic, which emphasised the need to urgently modernise outdated EU pharmaceutical law and revise regulatory ambitions in the MedTech sector.

Medical 117

Medical Government Marketing Medicine 117

PharmaTimes

FEBRUARY 9, 2023

The companies anticipate that the EMA could also recommend marketing authorisation for AVT04

Marketing 109

Marketing 109

Fierce Pharma

FEBRUARY 7, 2023

AstraZeneca's Forxiga nabs expanded heart failure approval in Europe zbecker Tue, 02/07/2023 - 14:24

289

289

European Pharmaceutical Review

FEBRUARY 10, 2023

Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. has approved changes of its Representative Director, President and CEO and its management structure. Effective April 1, 2023, Naoki Okamura and Kenji Yasukawa will hold the following positions: Naoki Okamura is currently Representative Director, Executive Vice President of Astellas.

Management 105

Management Engineering Pharma Leads 105

MedCity News

FEBRUARY 7, 2023

Employers are most interested in switching up their vendor partners for wellbeing programs, the Willis Towers Watson survey found. About 55% of respondents said they will make changes to their wellbeing vendor partners in 2023 or 2024, while 12% already did in 2022.

119

119

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaTimes

FEBRUARY 10, 2023

Collaboration has created method for heart failure patients to receive at-home treatment

Patients 107

Patients 107

Fierce Pharma

FEBRUARY 8, 2023

Novartis, Bayer marshal relief for Turkey and Syria following devastating earthquake fkansteiner Wed, 02/08/2023 - 09:56

264

264

Pharmaceutical Technology

FEBRUARY 10, 2023

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and large market diseases, has had the FDA place a clinical hold onto its Fabry disease (FD) gene therapy program (4D-310). 4DMT had paused enrollment of patients to two of its trials for 4D-310 last month following a significant adverse event where three patients experienced kidney issues; however, these were treated and resolved in a four-week period. 4DMT has stated that

FDA 105

FDA Leads Competition Marketing 105

MedCity News

FEBRUARY 7, 2023

For anyone suffering from a debilitating or life-threatening disease, the experience of procuring specialty medications […]

Medical 118

Medical Physicians 118

Advertisement

PharmaTimes

FEBRUARY 10, 2023

Study involves the treatment of adults with moderate-to-severe chronic hand eczema

106

106

Fierce Pharma

FEBRUARY 7, 2023

ICER chief's agenda: Gene therapy differentiation, post-IRA model updates and more aliu Tue, 02/07/2023 - 10:30

264

264

PharmExec

FEBRUARY 9, 2023

Examining efforts to boost women representation on company boards.

Government 105

Government Pharma 105

MedCity News

FEBRUARY 8, 2023

Suicide-related diagnoses in children and adolescents increased 14% since before the pandemic, a new Evernorth analysis shows. Female and Asian/Pacific Islander youth are especially struggling.

116

116

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

FEBRUARY 7, 2023

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Takeda ’s dengue virus vaccine candidate, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]). The vaccine candidate has been approved for active immunisation against the infection in people from four years of age. Qdenga has been developed based on a live-attenuated dengue serotype 2 virus that offers the genetic backbone for four dengue virus serotypes.

Safety 105

Safety Medicine Healthcare Healthcare 105

Fierce Pharma

FEBRUARY 7, 2023

Despite high-profile media coverage, FDA balks at GSK's 'unprecedented' Jemperli proposal in rectal cancer aliu Tue, 02/07/2023 - 17:07

Media 263

Media FDA 263

European Pharmaceutical Review

FEBRUARY 9, 2023

Researchers have shown that a newly developed two-chamber setup (TCS) for containment investigations consisting of an emission and a detection chamber may predict highly potent active pharmaceutical ingredient (HPAPI) dustiness in a sealed system at different flow conditions. These different flow conditions include the plain diffusive transport and the diffusive transport with the oppositely directed convective flow of airborne particles of the safe surrogate substance acetaminophen (ACAM).

Transportation 105

Transportation Specialization Distribution Manufacturing 105

MedCity News

FEBRUARY 8, 2023

HLTH Foundation Executive Director Janna Guinen described its focus on promoting equity, inclusion and opportunity in healthcare on behalf of patients, healthcare professionals and health tech entrepreneurs.

Healthcare 114

Healthcare Healthcare Patients 114

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

FEBRUARY 5, 2023

The US Food and Drug Administration (FDA) has granted approval for Gilead Sciences ’ Trodelvy (sacituzumab govitecan-hziy) to treat unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH–) breast cancer adult patients. Trodelvy has been approved for HR+/HER2- breast cancer adult patients who have previously received endocrine-based therapy and a minimum of two additional systemic therapies

Food and Drug Administration 105

Food and Drug Administration FDA Physicians Food 105

Fierce Pharma

FEBRUARY 9, 2023

AstraZeneca met CEO Pascal Soriot's $40B revenue goal early.

246

246

European Pharmaceutical Review

FEBRUARY 7, 2023

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to RP-A501, an adeno-associated virus (AAV)-based gene therapy for Danon disease. “RP-A501 is the first cardiac gene therapy to receive RMAT designation from the FDA,” commented Dr Gaurav Shah, Chief Executive Officer at Rocket Pharmaceuticals.

Food and Drug Administration 105

Food and Drug Administration FDA Medicine Food 105

MedCity News

FEBRUARY 8, 2023

R&D spending rose in response to Covid-19, bringing with it higher expectations for returns on all biopharma investments. The once sky-high projections are coming down to Earth, with returns now in line with pre-pandemic levels, according to a new Deloitte report.

Biopharma 112

Biopharma Pharma 112

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

Pharmaceutical Technology

FEBRUARY 8, 2023

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases. In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

Fierce Pharma

FEBRUARY 9, 2023

Regeneron wins another FDA nod for powerhouse Eylea despite trial flops kdunleavy Thu, 02/09/2023 - 10:30

FDA 246

FDA 246

PharmaTimes

FEBRUARY 8, 2023

The pathway is a programme designed to develop pharmacists’ knowledge of mental health among patients

Training 100

Training Patients 100

MedCity News

FEBRUARY 8, 2023

High prices have drawn other critics, as well, including President Joe Biden. He renewed his call for a broad price cap during his annual State of the Union address. Pharma companies insist they have been part of the solution.

Pharma 111

Pharma 111

Advertisement

Distribution